Table 2.
Primary and secondary outcomes at baseline and follow-up, by study arm
| Current modern family planning use, non-pregnant women only | Experience of IPV within past 12 months | |||||||
|---|---|---|---|---|---|---|---|---|
| Baseline n (%) |
p-valuea | Follow-up n (%) |
p-valuea | Baseline n (%) |
p-valuea | Follow-up n (%) |
p-valuea | |
| N (adolescent wives) | 933 | 843 | 1050 | 957 | ||||
| Overall | 110 (11.8%) | 323 (38.3%) | 93 (8.9%) | 94 (9.8%) | ||||
| Treatment status | 0.01 | 0.002 | 0.21 | 0.26 | ||||
| Control | 37 (17.0%) | 61 (29.2%) | 18 (6.9%) | 28 (11.7%) | ||||
| Intervention | 73 (10.2%) | 262 (41.3%) | 75 (9.5%) | 66 (9.2%) | ||||
| Study arm | < 0.001 | 0.01 | < 0.001 | 0.31 | ||||
| Control | 37 (17.0%) | 61 (29.2%) | 18 (6.9%) | 28 (11.7%) | ||||
| Arm 1—home visits only | 16 (6.3%) | 88 (40.0%) | 11 (3.9%) | 23 (9.0%) | ||||
| Arm 2—group sessions only | 38 (17.1%) | 80 (40.4%) | 26 (10.6%) | 16 (7.2%) | ||||
| Arm 3—home visits and group sessions | 19 (8.0%) | 94 (43.5%) | 38 (14.6%) | 27 (11.3%) | ||||
aFisher’s exact test